OPTIVIA BIOTECHNOLOGY, INC.

Company Information

Company Name
OPTIVIA BIOTECHNOLOGY, INC.
Address
115 CONSTITUTION DR, STE 7
MENLO PARK, CA, 94025-3712
Phone
n/a
URL
n/a
DUNS
804420029
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$996,315.00
3
SBIR Phase II
$3,649,397.00
2
Chart code to be here

Award List

  1. A Transporter-Based Predictive ADME Platform

    Amount: $439,346.00

    DESCRIPTION (provided by applicant): Desirable drug ADME (Absorption, Disposition, Metabolism and Elimination) properties are key determinants of a drug's to safety and efficacy. Unfortunately, poor A ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Development of A Comprehensive Cell-Based Transporter Assay Platform

    Amount: $406,969.00

    DESCRIPTION (provided by applicant): Transporters are a class of more than 300 membrane proteins that regulate how nutrients and drugs enter and leave biological cells. Transporters have validated cli ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies

    Amount: $1,847,303.00

    DESCRIPTION (provided by applicant): Transporters are a class of more than 1000 membrane proteins that regulate how nutrients and drugs enter and leave biological cells. Transporters have validated cl ...

    SBIR Phase II 2011 Department of Health and Human Services
  4. Establishing a comprehensive inhibitory profile of marketed drugs against CNS tra

    Amount: $150,000.00

    DESCRIPTION (provided by applicant): CNS Transporters have crucial roles on neurophysiology and etiology. Inhibition of these critical transporters can have therapeutic benefits or cause serious side ...

    SBIR Phase I 2011 Department of Health and Human Services
  5. A Comprehensive Platform to study drug interaction with physiologically important

    Amount: $1,802,094.00

    CNS Transporters have crucial roles on neurophysiology and etiology. Inhibition of these critical transporters can have therapeutic benefits or cause serious side effects in the CNS. Development of an ...

    SBIR Phase II 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government